General, N.B. Reg. 2014-27

Section 28

Formulary

Cite as General, N.B. Reg. 2014-27, s. 28 · current to November 1, 2026 · read from New Brunswick Acts and Regulations on November 16, 2026

The text

(1) A request under subsection 29(4) of the Act shall be made on a form provided by the Minister and signed by a provider or medical practitioner. (2) For the purposes of subsection 29(4) of the Act, the information to be provided is as follows: (a) the name, dosage form, strength and treatment schedule of the drug; (b) whether the request is for an approval of a brand name product when a pharmaceutical equivalent or a pharmaceutical alternative is available; (c) clinical information that outlines the request of the member of the Plan; (d) outcome measures to support continued use and to stop treatment; (e) supporting laboratory tests and objective clinical measures; (f) details of previous treatment with other therapies or products, if applicable; (g) details of availability of the drug to the member of the Plan from other sources; and (h) supporting published data and evidence for use.
Read the General on the Province's website ↗

Made under Prescription and Catastrophic Drug Insurance Act, 2014, c.4.